Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Grundmann

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Computational and Structural Biotechnology Journal|January 27, 2025
Development of a new data management system for the study of the gut microbiome of children who are small for their gestational ageFelix Manske, Magdalena Durda-Masny, Norbert Grundmann, et al.
Scientific Reports|July 13, 2022
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patientsKatrin Schlack, Konstantin Seitzer, Neele Wüstmann, et al.
Biomarker Research|April 4, 2023
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancerNeele Wüstmann, Konstantin Egon Seifert, Verena Humberg, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Computational and Structural Biotechnology Journal|January 27, 2025
Development of a new data management system for the study of the gut microbiome of children who are small for their gestational ageFelix Manske, Magdalena Durda-Masny, Norbert Grundmann, et al.
Scientific Reports|July 13, 2022
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patientsKatrin Schlack, Konstantin Seitzer, Neele Wüstmann, et al.
Biomarker Research|April 4, 2023
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancerNeele Wüstmann, Konstantin Egon Seifert, Verena Humberg, et al.
Pageof 2